Pfizer Cuts Recifercept for Achondroplasia Program
Pfizer punts pair of orphan drugs amid rare disease R&D rethink Pfizer, amid a rethink of its rare disease R&D strategy, has punted (PDF) a pair of orphan drug candidates from its…
Pfizer
Achondroplasia · Ascendis · BioMarin · Hypochondroplasia · Limb Lengthening · Pfizer · QED · Skeletal Dysplasia
The Perfect Date: National DNA Day
The perfect date: April 25th…because it’s not too hot, not too cold. All you need is a light jacket…Oh! And it’s also #NationalDNADay! National DNA Day is a global movement…
Key Measurement Concepts and Appropriate Clinical Outcome Assessments in Pediatric Achondroplasia Clinical Trials
Author(s): Natalie Aldhouse, MSc (Presenting Author); Helen Kitchen, MSc (Co-Author); Chloe Johnson, MSc (Co-Author); Chris Marshall, MSc (Co-Author); Hannah Pegram, BSc (Co-Author); Sheryl Pease, MBA PMP (Co-Author); Sam Collins, MD (Co-Author);…
Achondroplasia · Ascendis · BioMarin · Pfizer · QED
Prospects for Pharmaceutical Treatment of Achondroplasia
John B. Cannon, Ph.D Achondroplasia is a form of dwarfism that occurs about once in every 20,000 births. It arises from a defect in the process of bone growth in…